株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アムロジピンの中国市場の分析

Investigation Report on China's Amlodipine Market, 2018-2022

発行 China Research and Intelligence 商品コード 758395
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.82円で換算しております。
Back to Top
アムロジピンの中国市場の分析 Investigation Report on China's Amlodipine Market, 2018-2022
出版日: 2018年12月13日 ページ情報: 英文 30 Pages
概要

当レポートでは、中国のアムロジピン市場について調査分析し、状況、市場規模、主要メーカー、市場競合、小売価格、市場の見通しについて、体系的な情報を提供しています。

第1章 アムロジピンの関連概念

  • 適応
  • 中国の発展
  • 中国政府の承認

第2章 中国におけるアムロジピンの売上

  • 売上高
  • 売上数量
  • 売上:剤形別

第3章 中国におけるアムロジピン主要メーカーの分析

  • 市場シェア分析
  • Pfizer
  • Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.
  • China Resources Saike Pharmaceutical Co., Ltd.
  • Kunming Sinoway Natural Pharmaceuticals
  • Suzhou Dawnrays Pharmaceutical Co., Ltd.

第4章 中国におけるアムロジピンの価格

  • Pfizer (Norvasc)
  • Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd. (Landi)
  • China Resources Saike Pharmaceutical Co., Ltd. (Yashida)
  • Kunming Sinoway Natural Pharmaceuticals (Xinluoping)
  • Suzhou Dawnrays Pharmaceutical Co., Ltd. (Anneizhen)

第5章 中国のアムロジピンの市場の見通し

  • 市場規模の予測
  • 市場動向の予測
目次
Product Code: 1812355

The incidence of hypertension is increasing in China with the development of economy, the change of lifestyle and the aging of the population. It is estimated that at the end of 2017, there were about 330 million hypertensive patients in China, i.e., one in every three Chinese adults has high blood pressure. With the increasing number of hypertensive patients, the market size of antihypertensive drugs is also growing.

Amlodipine is a third-generation calcium antagonist used to treat chronic stable angina and hypertension. It can reduce the risk of hospitalization for angina and the risk of coronary revascularization. The brand-name Amlodipine is Pfizer's Norvasc. In 1989, Amlodipine tablets were launched in the U.K. under the trade name Istin, and Amlodipine capsules were launched in Belgium under the trade name Amlor. In 1992, Norvasc was approved by the FDA as a new molecular entity (NME).

According to CRI, after Amlodipine entered China, the market size of Amlodipine kept rising until 2013. From 2013 to 2017, however, the sales revenue declined because of the fall in average price and the competition from other antihypertensive drugs. Apart from Pfizer's Norvasc, generic drugs by Chinese companies have been marketed successively. The CFDA has issued dozens of Amlodipine production approvals, which means that there are dozens of Amlodipine manufacturers on the market. But the market is still dominated by Pfizer's brand-name drug. In 2017, the market size of Amlodipine in China was about CNY 730 million. By sales value, the market share of Pfizer exceeded 80%. The other major market players were Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd., China Resources Saike Pharmaceutical Co., Ltd., Kunming Sinoway Natural Pharmaceuticals, and Suzhou Dawnrays Pharmaceutical Co., Ltd.

It is expected that as the incidence of hypertension continues to increase, China's Amlodipine market will still have some growth potential in the next few years.

Topics Covered:

  • Situation of hypertension in China
  • Sales of Amlodipine in China
  • Competition on China's Amlodipine market
  • Prices of Amlodipine in China from 2017 to 2018
  • Factors influencing the development of China's Amlodipine market
  • Prospect of China's Amlodipine market

Table of Contents

1. Relevant Concepts of Amlodipine

  • 1.1. Indications for Amlodipine
  • 1.2. Development of Amlodipine in China
  • 1.3. Governmental Approval of Amlodipine in China

2. Sales of Amlodipine in China, 2013-2017

  • 2.1. Sales Value of Amlodipine
    • 2.1.1. Overall Sales Value
    • 2.1.2. Sales Value by Region
  • 2.2. Sales Volume of Amlodipine
    • 2.2.1. Overall Sales Volume
    • 2.2.2. Sales Volume by Region
  • 2.3. Sales of Amlodipine by Dosage Form in China, 2013-2017
    • 2.3.1. Capsules
    • 2.3.2. Tablets
    • 2.3.3. Pills

3. Analysis on Major Amlodipine Manufacturers in China, 2013-2017

  • 3.1. Analysis on Market Share of Major Amlodipine Manufacturers
    • 3.1.1. Market Share by Sales Value
    • 3.1.2. Market Share by Sales Volume
  • 3.2. Pfizer
    • 3.2.1. Profile of Pfizer
    • 3.2.2. Sales of Pfizer's Amlodipine in China
  • 3.3. Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.
    • 3.3.1. Profile of Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.
    • 3.3.2. Sales of Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.'s Amlodipine in China
  • 3.4. China Resources Saike Pharmaceutical Co., Ltd.
  • 3.5. Kunming Sinoway Natural Pharmaceuticals
  • 3.6. Suzhou Dawnrays Pharmaceutical Co., Ltd.

4. Prices of Amlodipine in China, 2017-2018

  • 4.1. Pfizer (Norvasc)
  • 4.2. Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd. (Landi)
  • 4.3. China Resources Saike Pharmaceutical Co., Ltd. (Yashida)
  • 4.4. Kunming Sinoway Natural Pharmaceuticals (Xinluoping)
  • 4.5. Suzhou Dawnrays Pharmaceutical Co., Ltd. (Anneizhen)

5. Prospect of China's Amlodipine Market, 2018-2022

  • 5.1. Forecast on Market Size
  • 5.2. Forecast on Market Trend

Selected Charts:

  • Chart Governmental Approval of Amlodipine in China
  • Chart Sales of Amlodipine in China, 2013-2017
  • Chart Sales Value of Amlodipine in Parts of China, 2013-2017
  • Chart Sales Volume of Amlodipine in China, 2013-2017
  • Chart Sales Volume of Amlodipine in Parts of China, 2013-2017
  • Chart Sales Value of Amlodipine Capsules in China, 2013-2017
  • Chart Sales Volume of Amlodipine Capsules in China, 2013-2017
  • Chart Sales Value of Amlodipine Tablets in China, 2013-2017
  • Chart Sales Volume of Amlodipine Tablets in China, 2013-2017
  • Chart Sales Value of Amlodipine Pills in China, 2013-2017
  • Chart Sales Volume of Amlodipine Pills in China, 2013-2017
  • Chart Market Share of Top 5 Amlodipine Manufacturers by Sales Value in China, 2013-2017
  • Chart Market Share of Top 5 Amlodipine Manufacturers by Sales Volume in China, 2013-2017
  • Chart Sales Value of Pfizer's Amlodipine in China, 2013-2017
  • Chart Sales Volume of Pfizer's Amlodipine in China, 2013-2017
  • Chart Sales Value of Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.'s Amlodipine in China, 2013-2017
  • Chart Sales Volume of Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.'s Amlodipine in China, 2013-2017
  • Chart Sales Value of China Resources Saike Pharmaceutical Co., Ltd.'s Amlodipine in China, 2013-2017
  • Chart Prices of Pfizer's Amlodipine in Parts of China, 2017-2018
  • Chart Prices of Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.'s Amlodipine in Parts of China, 2017-2018
  • Chart Prices of China Resources Saike Pharmaceutical Co., Ltd.'s Amlodipine in Parts of China, 2017-2018
  • Chart Prices of Kunming Sinoway Natural Pharmaceuticals' Amlodipine in Parts of China, 2017-2018
  • Chart Prices of Suzhou Dawnrays Pharmaceutical Co., Ltd.'s Amlodipine in Parts of China, 2017-2018
  • Chart Forecast on Sales Value of Amlodipine in China, 2018-2022
Back to Top